---
title: Diagnosis and classification of myelodysplastic syndromes
date: '2023-09-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37774372/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20230930180810&v=2.17.9.post6+86293ac
source: Blood
description: 'Myelodysplastic syndromes (MDSs) are neoplastic myeloid proliferations
  characterized by ineffective hematopoiesis resulting in peripheral blood cytopenias.
  MDS is distinguished from non-neoplastic clonal myeloid proliferations by the presence
  of morphologic dysplasia and from acute myeloid leukemia (AML) by a blast threshold
  of 20%. The diagnosis of MDS can be challenging due to the myriad other causes of
  cytopenias: accurate diagnosis requires the integration of clinical features with
  ...'
disable_comments: true
---
Myelodysplastic syndromes (MDSs) are neoplastic myeloid proliferations characterized by ineffective hematopoiesis resulting in peripheral blood cytopenias. MDS is distinguished from non-neoplastic clonal myeloid proliferations by the presence of morphologic dysplasia and from acute myeloid leukemia (AML) by a blast threshold of 20%. The diagnosis of MDS can be challenging due to the myriad other causes of cytopenias: accurate diagnosis requires the integration of clinical features with ...